⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MREO News
Mereo BioPharma Group plc American Depositary Shares
MREO DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Mereo BioPharma Group plc Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - MREO
accessnewswire.com
MREO
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
MREO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO
prnewswire.com
MREO
Form 8-K
sec.gov
MREO
Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights
globenewswire.com
MREO
MREO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Mereo BioPharma Group plc Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MREO
MREO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Mereo BioPharma Group plc Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MREO
Pomerantz LLP Informs Shareholders of Securities Class Action Against Mereo BioPharma Group plc – MREO
accessnewswire.com
MREO
MREO DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - MREO
accessnewswire.com
MREO
MREO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
globenewswire.com
MREO